We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zynex, Inc. (ZYXI - Free Report) engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The stock price has surged recently. The company has an expected earnings growth of double digits for the current year. The Zacks Consensus Estimate for the current year has improved by double digits over the last 30 days. A combination of strong price performance and favorable technical, suggests that this Zacks #1 Rank, Strong Buy, stock may be on the right path. We certainly think that this might be the case, particularly if you consider ZYXI’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable.
Meridian Bioscience, Inc. , is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers.The company came out with quarterly earnings that beat the Zacks Consensus Estimate. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Meridian Bioscience shares have added significantly since the beginning of the year.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.
These 7 were selected because of their superior potential for immediate breakout.
Top Stock Picks for Week of May 11, 2020
Zynex, Inc. (ZYXI - Free Report) engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The stock price has surged recently. The company has an expected earnings growth of double digits for the current year. The Zacks Consensus Estimate for the current year has improved by double digits over the last 30 days. A combination of strong price performance and favorable technical, suggests that this Zacks #1 Rank, Strong Buy, stock may be on the right path. We certainly think that this might be the case, particularly if you consider ZYXI’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable.
Meridian Bioscience, Inc. , is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers.The company came out with quarterly earnings that beat the Zacks Consensus Estimate. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Meridian Bioscience shares have added significantly since the beginning of the year.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>